Authors: Wallach, S Cohen, S Reid, DM Hughes, RA Hosking, DJ Laan, RF Doherty, SM Maricic, M Rosen, C Brown, J Barton, I Chines, AA

Citation: S. Wallach et al., Effects of risedronate treatment on bone density and vertebral fracture inpatients on corticosteroid therapy, CALCIF TIS, 67(4), 2000, pp. 277-285

Authors: Wallach, S Rousseau, G Martin, L Azria, M

Citation: S. Wallach et al., Effects of calcitonin on animal and in vitro models of skeletal metabolism, BONE, 25(5), 1999, pp. 509-516

Authors: McCloskey, EV Bone, H Rodan, G McClung, M Wallach, S Lyles, KW Grauer, A Mautelan, C Gutteridge, DH",Anderson,Hooper,Ralston,Sharpe,Posen

Citation: Ev. Mccloskey et al., Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion, J BONE MIN, 14, 1999, pp. 74-78

Authors: Cohen, S Levy, RM Keller, M Boling, E Emkey, RD Greenwald, M Zizic, TM Wallach, S Sewell, KL Lukert, BP Axelrod, DW Chines, AA

Citation: S. Cohen et al., Risedronate therapy prevents corticosteroid-induced bone loss - A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, ARTH RHEUM, 42(11), 1999, pp. 2309-2318